APUS

Peers: NXTT NAKA ASST GNS MSTR SQNS DJT ABTC BTCS GME

Index	-
Market Cap	4.38M
Enterprise Value	10.67M
Income	-58.17M
Sales	0.00M
Book/sh	70.54
Cash/sh	5.48
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	7
IPO	May 09, 2025

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.04
P/C	0.53
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.51
Current Ratio	0.51
Debt/Eq	0.14
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-36.71
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	-108.46% -
Sales past 3/5Y	- -
EPS Y/Y TTM	-1063.72%
Sales Y/Y TTM	-
EPS Q/Q	-456.18%
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	62.68%
Insider Trans	0.00%
Inst Own	2.82%
Inst Trans	-
ROA	-84.20%
ROE	-100.13%
ROIC	-54.59%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-34.52%
SMA50	-23.53%
SMA200	-73.95%
Trades

Shs Outstand	1.51M
Shs Float	0.56M
Short Float	14.20%
Short Ratio	0.02
Short Interest	0.08M
52W High	59.70 -95.14%
52W Low	1.51 92.05%
Volatility	12.95% 24.54%
ATR (14)	0.97
RSI (14)	41.00
Beta	0.05
Rel Volume	0.01
Avg Volume	3.70M
Volume	13,673

Perf Week	-17.14%
Perf Month	-60.00%
Perf Quarter	-63.75%
Perf Half Y	-84.57%
Perf YTD	-82.32%
Perf Year	-85.35%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	2.89
Price	2.90
Change %	0.35%

Oct-13-26 09:43AM	NILA Token to Begin Trading on Pionex, Opening Access to Eligible Users Worldwide (GlobeNewswire) -11.15%
Oct-09-26 06:00PM	MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disclosure (GlobeNewswire) -8.89%
Oct-05-26 08:00AM	MindWave Innovations Signs Agreement with US-Based BlockAssure to Build and Operate AssureChain, an End-to-End Insurance and Reinsurance Network (GlobeNewswire) +42.55%
Sep-29-26 08:30AM	MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media (GlobeNewswire) -21.44%
Sep-24-26 08:30AM	MindWave Innovations Signs Agreement to Build and Operate AQUAEChain, a Platform for Insured ALCI Credits (GlobeNewswire) +114.85%
09:00AM	Loading…
Aug-03-26 09:00AM	NILA Token Now Available to Eligible U.S. Users on Webot, a Licensed U.S. Cryptocurrency Exchange (GlobeNewswire) -5.83%
Jul-28-26 08:30AM	MindWave Innovations Inc., a Wholly Owned Subsidiary of Apimeds Pharmaceuticals US, Inc., Announces MindChain: World's First Fully Insured Blockchain, Launching in October (GlobeNewswire) +27.19%
Jul-07-26 09:30PM	Inside the ICE House x Las Vegas: MindWave Innovations CEO Dr. Vin Menon (NYSE) -13.66%

Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS). The company was founded on May 11, 2020 and is headquartered in Matawan, NJ.

PresidentMr. Erik C. Emerson

Founder & Co-CEODr. Vinod Menon

Co-CEO & DirectorMr. Sungjoon Chae

Chief Financial OfficerMr. Eric Michael Sherb C.P.A.

Chief Operating OfficerCaptain Sandeep Singh Yadav

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Apimeds Pharmaceuticals US Inc

Upgrade your Finviz experience